(R)-N-(3-(1H-tetrazol-5-yl)benzyl)-2-(3-(2-(3,4-dimethoxyphenyl)acetyl)guanidino)-4-methylpentanamide

ID: ALA3321935

Chembl Id: CHEMBL3321935

PubChem CID: 90294647

Max Phase: Preclinical

Molecular Formula: C25H32N8O4

Molecular Weight: 508.58

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(CC(=O)NC(=N)N[C@H](CC(C)C)C(=O)NCc2cccc(-c3nnn[nH]3)c2)cc1OC

Standard InChI:  InChI=1S/C25H32N8O4/c1-15(2)10-19(24(35)27-14-17-6-5-7-18(11-17)23-30-32-33-31-23)28-25(26)29-22(34)13-16-8-9-20(36-3)21(12-16)37-4/h5-9,11-12,15,19H,10,13-14H2,1-4H3,(H,27,35)(H3,26,28,29,34)(H,30,31,32,33)/t19-/m1/s1

Standard InChI Key:  NTQJBFMCEDXNFM-LJQANCHMSA-N

Associated Targets(Human)

CTSD Tchem Cathepsin D (3201 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
REN Tclin Renin (5251 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CTSD Cathepsin D (510 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 508.58Molecular Weight (Monoisotopic): 508.2547AlogP: 1.80#Rotatable Bonds: 11
Polar Surface Area: 167.00Molecular Species: ACIDHBA: 8HBD: 5
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.29CX Basic pKa: 8.18CX LogP: 1.28CX LogD: 1.23
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.19Np Likeness Score: -0.95

References

1. Grädler U, Czodrowski P, Tsaklakidis C, Klein M, Werkmann D, Lindemann S, Maskos K, Leuthner B..  (2014)  Structure-based optimization of non-peptidic Cathepsin D inhibitors.,  24  (17): [PMID:25086681] [10.1016/j.bmcl.2014.07.054]

Source